ADAG

Adagene American Depositary Shares (ADAG)

About Adagene American Depositary Shares (ADAG)

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Details

Daily high

$2.07

Daily low

$1.97

Price at open

$2.06

52 Week High

$4.38

52 Week Low

$1.74

Market cap

86.8M

Dividend yield

0.00%

Volume

10,082

Avg. volume

100,212

P/E ratio

-2.69

Adagene American Depositary Shares News